Connection
Paul Bunn to Tumor Escape
This is a "connection" page, showing publications Paul Bunn has written about Tumor Escape.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.136 |
|
|
|
-
He Y, Liu S, Mattei J, Bunn PA, Zhou C, Chan D. The combination of anti-KIR monoclonal antibodies with anti-PD-1/PD-L1 monoclonal antibodies could be a critical breakthrough in overcoming tumor immune escape in NSCLC. Drug Des Devel Ther. 2018; 12:981-986.
Score: 0.136